Abstract
The biological effects of prostacyclin (PGI2) are mediated by activation of adenylate cyclase. In most respects the biochemical events that accompany occupation by agonist of specific PGI2 receptors on “target tissues” are similar to those described for numerous other neurotransmitter and hormonal systems.
Preview
Unable to display preview. Download preview PDF.
References
Siegl AM, Smith B, Silver MJ, Nicolaou KC, Ahern D (1979) Selective binding site for [3H] prostacyclin on platelets. J Clin Invest 63: 215–220
Shepherd GL, Lewis PJ, Blair IA, de Mey C, MacDermot J (1983) Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects. Br J Clin Pharmacol 15: 77–81
MacDermot J, Barnes PJ, Waddell KA, Dollery CT, Blair IA (1981) Prostacyclin binding to guinea pig pulmonary receptors. Eur J Pharmacol 75: 127–130
Blair IA, MacDermot J (1981) The binding of [3H]-prostacyclin to membranes of a neuronal somatic hybrid. Br J Pharmacol 72: 435–441
Shepherd GL (1984) Platelet prostacyclin receptors. MD Thesis, University of London
Blair IA, Cresp TM, MacDermot J (1981) Divalent cations increase [3H]-prostacyclin binding to membranes of neuronal somatic hybrid cells. Br J Pharmacol 73: 691–694
MacDermot J, Blair IA, Cresp TM (1981) Prostacyclin receptors of a neuronal hybrid cell line. Divalent cations and ligand-receptor coupling. Biochem Pharmacol 30: 2041–2044
Leigh PJ, Cramp WA, MacDermot J (1984) Identification of the prostacyclin receptor by radiation inactivation. J Biol Chem 259: 12431–12436
Rodbell M (1980) The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284: 17–22
Blair IA, Hensby CN, MacDermot J (1980) Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic cell hybrid: prostanoid structure-activity relationships. Br J Pharmacol 69: 519–525
Gorman RR, Hopkins NK (1980) Agonist-specific desensitization of PGI2-stimulated cyclic AMP accumulation by PGE1 in human foreskin fibroblasts. Prostaglandins 19: 2–16
Sinzinger H, Silberbauer K, Horsch AK, Gall A (1981) Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease — a rebound phenomenon? Prostaglandins 21: 49–51
Miller OV, Gorman RR (1979) Evidence for distinct prostaglandin I2 and D2 receptors in human platelets. J Pharmacol Exp Ther 210: 134–140
Blair IA, Leigh PJ, MacDermot J (1982) Desensitization of prostacyclin receptors in a neuronal hybrid cell line. Br J Pharmacol 77: 121–127
Leigh PJ, MacDermot J (1985) Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors. Br J Pharmacol 85: 237–247
Homburger V, Lucas M, Cantau B, Barabe J, Penit J, Bockaert J (1980) Further evidence that desensitization of β-adrenergic-sensitive adenylate cyclase proceeds in two steps. J Biol Chem 255: 10436–10444
Patrono C, Pugliese F, Ciabattoni G, Patrignani P, Maseri A, Chierchia S, Peskar BA, Cinotti GA, Simonetti BM, Pierucci A (1982) Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest 69: 231–239
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
MacDermot, J. et al. (1987). Desensitization of Iloprost or Prostacyclin Responsiveness. In: Gryglewski, R.J., Stock, G. (eds) Prostacyclin and Its Stable Analogue Iloprost. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71499-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-71499-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71501-3
Online ISBN: 978-3-642-71499-3
eBook Packages: Springer Book Archive